Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
Clinical trial NCT05809830 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05809830
- Sponsor
- Grupo Espanol de Investigacion en Sarcomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-29
- Primary completion
- 2025-06-20
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.